Tag: marijuana reclassification

  • THC Breathalyzer That Uses Nano Tech Faces Federal Road Blocks

    THC Breathalyzer That Uses Nano Tech Faces Federal Road Blocks

    Nanotechnology may help law enforcement measure driver impairment due to marijuana use.

    NPR has reported on the development of a breathalyzer-type device that could be used by police to detect if an individual’s ability to drive is impaired by THC.

    The device, announced by researchers from the University of Pittsburgh, uses nanontechnology to determine the presence of THC in a driver’s breath in a manner similar to how breathalyzers can analyze alcohol impairment. 

    The device – currently in prototype form – is the latest in a series of attempts to provide law enforcement with technological assistance in preventing traffic accidents and fatalities due to impairment; however, the roadblocks that have prevented those inventions from entering the mass market – namely, accurate levels of impairment and marijuana’s status as a Schedule I drug, which prevents research – also stand in the path of the new device’s further development.

    Carbon Nanotubes Key To Marijuana Breathalyzer

    The prototype for the device was constructed by Alexander Star, a chemistry professor who oversees the Star Lab at the University of Pittsburgh, with electrical and computer engineering professor Ervin Sedjic, who began work in 2016.

    As NPR noted, the device uses carbon nanotubes – cylindrical molecules made of rolled-up sheets of single layer carbon atoms that measure less than 1/100,000 the size of a human hair that can be used in electronic, chemical and electrochemical devices – which bind to the molecules in THC – the psychoactive component in cannabis – when detected.

    Lab tests showed that the nanotubes were able to detect THC in a breath sample that also contained components of carbon dioxide, ethanol, water, and acetone. The developers also established a baseline for THC in the device, which they claimed could avoid one of the lingering problems with other breathalyzer prototypes – the propensity for THC to remain in the bloodstream for weeks and even months after use, which skews the ability to determine if a driver is actually impaired while behind the wheel of a vehicle.

    According to a press release from the university’s Swanson School of Engineering, nanotechnology can “detect THC at levels comparable to or better than mass spectrometry, which is considered the gold standard for THC detection.”

    If the researchers are able to find an industrial partner, they said the device could be ready in “a few months.”

    Marijuana Still A Schedule I Drug

    But even that may not be enough to make the researchers’ device stand out from its predecessors. Sedjic acknowledged that conducting any researching using marijuana remains a challenge in the US due to its classification as a Schedule I drug and illegal by federal standards.

    Without that information, researchers are faced with determining levels of impairment without the actual substance that caused the impairment; further hampering their end goal is the lack of cohesive or scientifically sound data that determines the level of impairment.

    Currently, there are different rules in most states as to what constitutes THC impairment.

    But as legalization efforts continue to mount in the United States, the researchers are hopeful that the government will take the necessary steps to allow more testing in order to put forward devices such as theirs for law enforcement.

    “I think there will be some push even for the federal government to actually allow researchers to look and correlate these levels of smoking and impairment,” said Sedjic to NPR. 

    View the original article at thefix.com

  • World Health Organization To UN: Reclassify Cannabis

    World Health Organization To UN: Reclassify Cannabis

    WHO is calling for the classification to be updated to reflect the medical uses of marijuana.

    The World Health Organization is calling on the United Nations to change the classification of cannabis to acknowledge that the drug does have some medicinal purposes. 

    According to Futurism, cannabis is currently considered a Schedule IV drug by the UN. This designation is the most tightly controlled, and reserved for drugs that show “particularly dangerous properties.” It was set by an international drug treaty passed in 1961. 

    However, according to information published in the journal BMJ, the World Health Organization is calling for the classification to be updated to reflect the medical uses of marijuana

    “The World Health Organization has proposed rescheduling cannabis within international law to take account of the growing evidence for medical applications of the drug, reversing its position held for the past 60 years that cannabis should not be used in legitimate medical practice,” the report authors wrote

    According to the report, The WHO Expert Committee on Drug Dependence started reconsidering marijuana’s classification last year. The committee released a report with its findings and recommendations. 

    “The Committee concluded that the inclusion of cannabis and cannabis resin in Schedule IV is not consistent with the criteria for a drug to be placed in Schedule IV,” the report reads. 

    It goes on to recommend that marijuana and its compounds be reclassified as Schedule I or II drugs, which are less tightly controlled. The recommendations could be voted on by the United Nations member countries as soon as March, which would change the way that marijuana is handled under international law.

    However, it would have no bearing on how cannabis is scheduled federally in the United States, which uses an entirely different system of classification.

    Still, marijuana advocates, including a US Air Force veteran Michael Krawitz, said that the reclassification is long overdue. 

    “The placement of cannabis in the 1961 treaty, in the absence of scientific evidence, was a terrible injustice,” he told Forbes. “Today the World Health Organization has gone a long way towards setting the record straight. It is time for us all to support the World Health Organization’s recommendations and ensure politics don’t trump science.”

    Kenzi Riboulet Zemouli, the head of research at Paris-based non-profit For Alternative Approaches to Addiction Think & Do Tank, told Leafly that the measure is “a beginning of a new evidence and health-oriented cycle for international Cannabis policy.”

    “This is the best outcome that WHO could possibly have come up with,” Riboulet Zemouli said. 

    View the original article at thefix.com